Clinical Trial Update: A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update evaluating Strontium-90 beta radiation in combination with Lucentis (ranibizumab) for age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)
• Strontium-90 Beta Radiation Therapy

Snippet

Sponsor: NeoVista | Conditions: Macular Degeneration | Phase 3 | Status: UNKNOWN